Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
An announcement from Sanara MedTech ( (SMTI) ) is now available.
Sanara MedTech Inc. announced significant changes to its Board of Directors with the resignation of long-serving director James “Jim” Stuckert, who will remain as Director Emeritus, and the appointment of Keith Myers, an esteemed figure in the home health industry. Myers, recognized for his leadership and contributions to healthcare policy, will bring his strategic vision and experience to Sanara’s next growth phase. His appointment is expected to bolster the company’s expertise as it continues to advance in the surgical, chronic wound, and skincare markets.
Find detailed analytics on SMTI stock on TipRanks’ Stock Analysis page.
